Detecting Bone Marrow Metastases in Small Cell Lung Cancer
Author Information
Author(s): V. Trillet, D. Revel, V. Combaret, M. Favrot, R. Loire, A. Tabib, J. Pages, P. Jacquemet, A. Bonmartin, J.F. Mornex, J.F. Cordier, F. Pinet, M. Amie, J. Brunel
Primary Institution: Hopital Louis Pradel, Lyon, France
Hypothesis
Can magnetic resonance imaging and monoclonal antibodies improve the detection of bone marrow metastases in small cell lung cancer compared to conventional methods?
Conclusion
Magnetic resonance imaging and monoclonal antibodies can detect bone marrow metastases in small cell lung cancer more effectively than routine procedures.
Supporting Evidence
- Bone marrow metastases are found in 15-30% of patients with small cell lung cancer using routine methods.
- Magnetic resonance imaging and immunostaining detected malignant cells in 38% of cases where routine procedures were negative.
- One patient had metastatic disease detected only by MRI and immunostaining.
Takeaway
Doctors can use special imaging and tests to find cancer in the bone marrow of lung cancer patients better than before.
Methodology
The study involved 35 patients with small cell lung cancer, using magnetic resonance imaging and monoclonal antibodies to detect bone marrow involvement, compared to conventional methods.
Limitations
The study may not fully represent all patients with small cell lung cancer, and further investigation is needed to confirm the prognostic value of the new methods.
Participant Demographics
33 men and 2 women, median age of 61 years.
Want to read the original?
Access the complete publication on the publisher's website